Magnesiocard (Magnesium L-Aspartate Hydrochloride Trihydrate)

After ingestion, the compound dissociates, releasing magnesium ions that act as cofactors for many enzymatic processes. The magnesium replenishes intracellular stores, stabilises cell membranes, and participates in ATP production, nerve transmission, and muscle contraction, thereby normalising physiological functions that depend on adequate magnesium.

The appropriate dose of Magnesiocard is determined by a qualified prescriber based on the individual’s clinical condition, serum magnesium level, age, renal function and other factors. Patients should follow the healthcare professional’s instructions and not self‑adjust the dosage.

Safety in pregnancy and lactation has not been fully established. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss the use of Magnesiocard with their healthcare provider, who can weigh potential benefits against any possible risks.

To request Magnesiocard, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Magnesiocard delivers magnesium as the L‑aspartate salt, which may offer better gastrointestinal tolerance and bioavailability compared with some inorganic salts such as magnesium oxide. However, clinical effectiveness varies among individuals, and choice of supplement should be guided by a healthcare professional.

Store Magnesiocard below 25 °C in its original packaging, protecting it from moisture and direct sunlight. Keep the product out of reach of children and avoid exposing it to extreme temperatures or humidity, which could affect its stability.

Magnesiocard is taken orally, usually with a glass of water. It can be taken with or without food, but if gastrointestinal upset occurs, it may be helpful to ingest it with meals. Follow the prescriber’s directions regarding timing and frequency.

The most serious risk is hypermagnesemia, especially in patients with renal impairment or those taking other magnesium‑containing products. Excess magnesium can lead to cardiac arrhythmias, low blood pressure, muscle weakness, and in severe cases, respiratory depression. Monitoring serum levels is essential in high‑risk individuals.

Magnesiocard should be avoided by individuals with severe renal failure, uncontrolled heart block, or known hypersensitivity to magnesium salts. Patients on certain medications, such as aminoglycoside antibiotics or potent diuretics, should consult their healthcare provider before use.